GlakoLens participated in the BioTurkey StartHub challenge along with 20 start-ups working on medical and pharmaceutical technologies. GlakoLens pitched it's 24-h continuous intraocular pressure monitoring contact lens technology to a prestigious jury of medical practitioners, investors and … Read More... about GlakoLens Attended to BioTurkey 2020 and Pitched in StartHub
GlakoLens
gives the ability to monitor intraocular pressure (IOP) fluctuations over an extended period,
allows doctors to formulate an earlier and more accurate diagnosis,
allows for the personalisation of drug and surgical therapeutic options.
24 HOUR IOP MONITORING
WITH A CONTACT LENS
DATA RECORD
AND PROCESSING
GLAUCOMA
2nd leading cause of blindness globally with no permanent cure
mostly caused by chronic ocular hypertension, elevated intraocular pressure (IOP)
NEWS
GlakoLens Participated in T-DEB Final Showcase
GlakoLens participated in T-DEB Final Showcase on March 3rd 2020. The showcase allowed GlakoLens to develop better relationships with innovative R&D companies and wrapped up the T-DEB journey of 2 years. The T-DEB programme is funded by Innovate UK‘s Newton Fund. T-DEB is committed to … Read More... about GlakoLens Participated in T-DEB Final Showcase
